GALLANT 2 Tesaglitazar vs. Placebo

PHASE3TerminatedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

November 30, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

Tesaglitazar

BEHAVIORAL

Dietary and Lifestyle counseling

Trial Locations (14)

Unknown

Research Site, Hanko

Research Site, Helsinki

Research Site, Imatra

Research Site, Jakobstad

Research Site, Kokkola

Research Site, Kuopio

Research Site, Lahti

Research Site, Mikkeli

Research Site, Oulu

Research Site, Ödet

Research Site, Pattijoki

Research Site, Pori

Research Site, Tampere

Research Site, Turku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00252772 - GALLANT 2 Tesaglitazar vs. Placebo | Biotech Hunter | Biotech Hunter